Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Apiam Animal Health Limited
  6. News
  7. Summary
    AHX   AU000000AHX0

APIAM ANIMAL HEALTH LIMITED

(AHX)
  Report
Delayed Australian Stock Exchange  -  10:43:42 2023-01-24 pm EST
0.6150 AUD   -0.81%
2022Apiam Animal Health Completes Horse Veterinary Business Acquisition in New South Wales
MT
2022Apiam Animal Health Limited Completion of Hunter Equine Centre Acquisition
AW
2022Apiam Animal Health Limited (asx : AHX) Completion of Hunter Equine Centre Acquisition
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Apiam Animal Health Limited (ASX:AHX) Announce Board Renewal and Key AGM Dates

09/29/2022 | 08:32pm EST

Bendigo, Australia, Sep 30, 2022 - (ABN Newswire) - Apiam Animal Health Limited (ASX:AHX) is pleased to announce the appointment of Ms Evonne Collier as a Non-Executive Director to the Company's Board of Directors, with effect from 1 October.

Ms Collier joins the Apiam Board with significant Company Director and strategic leadership experience in many areas including business scale-up, commercial transformation and digital disruption. She also has considerable multinational experience across sales, marketing and Software as a Service in industries spanning pharmaceutical, animal health, MedTech, FinTech, eCommerce/Digital and consumer goods.

"I'm very pleased to welcome Evonne to the Company's Board of Directors. She offers the Apiam Board a skillset that is highly complementary to skillsets of the other directors and her leadership and experience will strengthen the implementation of our Accelerated Growth strategy that we have mapped out over the next two years", said Professor Andrew Vizard, Chair of Apiam.

Ms Collier will stand for election at Apiam's AGM on 24 November 2022.

Also today, Mr Mike van Blommestein has announced that he will retire as a Non-Executive Director of Apiam and not seek re-election when his term expires at the upcoming 2022 AGM on 24 November 2022. Mr van Blommestein has been on the Board of Apiam since the time of the Company's Initial Public Offering in December 2015 and has been the Chair of the Remuneration and Nomination Committee throughout this period.

"Mike has been a distinguished Director of Apiam and in particular made an important contribution to the governance and strategic oversight of our Company. I thank and congratulate Mike on his service and wish him all the best on his future endeavors", said Professor Vizard.

Evonne Collier

Ms Collier has served as a Chair and Non-Executive Director on various boards since 2011 and currently serves as a Director of 4DMedical Limited (ASX:4DX) as well as a number of private and public unlisted companies.
She currently serves as Non-Executive Director of global SaaS analytics company, Sage Automation (Chair of the Digital Products board), SaaS FinTech, Sniip (Remuneration and Nominations Chair), digital dental company, Curae Health (Chair), global eCommerce business, Australian Fitness Supplies (Chair) and Motorama Group Automotive Holdings (Chair of the Marketing and Digital Committee).

Ms Collier was also previously Non-Executive Director of ASX-listed 1300Smiles Limited (ASX:ONT) and Think Childcare Limited (ASX:TNK) prior to its acquisition in 2021.

Ms Collier holds a Master of Business (Marketing, Strategy and Innovation), Bachelor of Arts, Graduate Certificate of Applied Finance, and is a Graduate Member of the Australian Institute of Company Directors.

*To view the AGM Meeting dates, please visit:
https://abnnewswire.net/lnk/9H22AE83


<b>About Apiam Animal Health Limited:</b>

Apiam Animal Health Limited (ASX:AHX) is comprised of Australia's leading Production Animal and Mixed Animal veterinary practices.

Apiam Animal Health incorporates over 150 highly experienced, industry leading veterinarians with expertise across the pig, dairy, feedlot, sheep, poultry, equine, and companion animal sectors, supported by an experienced administration, nursing, technical services and ancillary team.

Apiam Animal Health is fully vertically integrated, including having veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services.

<b>Contact:</b>

Dr Chris Richards
Managing Director
Apiam Animal Health Limited
E: chris@apiam.com.au

Catherine Ross
Investor Relations
E: catherine.ross@apiam.com.au
T: 0421 997 481

Copyright (C) 2022 ABN Newswire. All rights reserved., source Press Releases English

Stocks mentioned in the article
ChangeLast1st jan.
APIAM ANIMAL HEALTH LIMITED -0.81% 0.615 Delayed Quote.-3.15%
RAMSAY HEALTH CARE LIMITED -1.03% 67.3 Delayed Quote.4.02%
All news about APIAM ANIMAL HEALTH LIMITED
2022Apiam Animal Health Completes Horse Veterinary Business Acquisition in New South Wales
MT
2022Apiam Animal Health Limited Completion of Hunter Equine Centre Acquisition
AW
2022Apiam Animal Health Limited (asx : AHX) Completion of Hunter Equine Centre Acquisition
AQ
2022Apiam Animal Health Limited Acquisition of Hunter Equine Centre
AW
2022Apiam Animal Health Limited (asx : AHX) Acquisition of Hunter Equine Centre
AQ
2022Apiam Animal Health Limited acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.
CI
2022Apiam Animal Health to Issue 284,628 Securities
MT
2022Apiam Animal Health Changes Registered Address
MT
2022Apiam Animal Health Limited Investor Update
AW
2022Apiam Animal Health Limited entered into an agreement to acquire Harradine and Associat..
CI
More news
Financials
Sales 2023 195 M 138 M 138 M
Net income 2023 10,1 M 7,16 M 7,16 M
Net Debt 2023 48,2 M 34,2 M 34,2 M
P/E ratio 2023 10,4x
Yield 2023 3,74%
Capitalization 108 M 76,8 M 76,8 M
EV / Sales 2023 0,80x
EV / Sales 2024 0,73x
Nbr of Employees 950
Free-Float 56,8%
Chart APIAM ANIMAL HEALTH LIMITED
Duration : Period :
Apiam Animal Health Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APIAM ANIMAL HEALTH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,62 AUD
Average target price 0,94 AUD
Spread / Average Target 52,8%
EPS Revisions
Managers and Directors
Christopher Irwin Richards Managing Director & Executive Director
Matthew White Chief Financial Officer
Andrew Lancelot Vizard Independent Non-Executive Chairman
Brian Scutt Chief Operating Officer
Richard John Dennis Independent Non-Executive Director